96 related articles for article (PubMed ID: 18610753)
1. Effects of morin on the bioavailability of tamoxifen and its main metabolite, 4-hydroxytamoxifen, in rats.
Shin SC; Piao YJ; Choi JS
In Vivo; 2008; 22(3):391-5. PubMed ID: 18610753
[TBL] [Abstract][Full Text] [Related]
2. Effects of epigallocatechin gallate on the oral bioavailability and pharmacokinetics of tamoxifen and its main metabolite, 4-hydroxytamoxifen, in rats.
Shin SC; Choi JS
Anticancer Drugs; 2009 Aug; 20(7):584-8. PubMed ID: 19491656
[TBL] [Abstract][Full Text] [Related]
3. Effects of curcumin on the pharmacokinetics of tamoxifen and its active metabolite, 4-hydroxytamoxifen, in rats: possible role of CYP3A4 and P-glycoprotein inhibition by curcumin.
Cho YA; Lee W; Choi JS
Pharmazie; 2012 Feb; 67(2):124-30. PubMed ID: 22512082
[TBL] [Abstract][Full Text] [Related]
4. Enhanced bioavailability of tamoxifen after oral administration of tamoxifen with quercetin in rats.
Shin SC; Choi JS; Li X
Int J Pharm; 2006 Apr; 313(1-2):144-9. PubMed ID: 16516418
[TBL] [Abstract][Full Text] [Related]
5. Effects of silybinin on the pharmacokinetics of tamoxifen and its active metabolite, 4-hydroxytamoxifen in rats.
Kim CS; Choi SJ; Park CY; Li C; Choi JS
Anticancer Res; 2010 Jan; 30(1):79-85. PubMed ID: 20150620
[TBL] [Abstract][Full Text] [Related]
6. Effects of baicalein on the pharmacokinetics of tamoxifen and its main metabolite, 4-hydroxytamoxifen, in rats: possible role of cytochrome P450 3A4 and P-glycoprotein inhibition by baicalein.
Li C; Kim M; Choi H; Choi J
Arch Pharm Res; 2011 Nov; 34(11):1965-72. PubMed ID: 22139696
[TBL] [Abstract][Full Text] [Related]
7. Reduced bioavailability of tamoxifen and its metabolite 4-hydroxytamoxifen after oral administration with biochanin A (an isoflavone) in rats.
Singh SP; Wahajuddin ; Raju KS; Ali MM; Kohli K; Jain GK
Phytother Res; 2012 Feb; 26(2):303-7. PubMed ID: 22131128
[TBL] [Abstract][Full Text] [Related]
8. Enhanced tamoxifen bioavailability after oral administration of tamoxifen in rats pretreated with naringin.
Choi JS; Kang KW
Arch Pharm Res; 2008 Dec; 31(12):1631-6. PubMed ID: 19099234
[TBL] [Abstract][Full Text] [Related]
9. Effects of oral kaempferol on the pharmacokinetics of tamoxifen and one of its metabolites, 4-hydroxytamoxifen, after oral administration of tamoxifen to rats.
Piao Y; Shin SC; Choi JS
Biopharm Drug Dispos; 2008 May; 29(4):245-9. PubMed ID: 18338336
[TBL] [Abstract][Full Text] [Related]
10. Effects of myricetin, an anticancer compound, on the bioavailability and pharmacokinetics of tamoxifen and its main metabolite, 4-hydroxytamoxifen, in rats.
Li C; Lim SC; Kim J; Choi JS
Eur J Drug Metab Pharmacokinet; 2011 Sep; 36(3):175-82. PubMed ID: 21442417
[TBL] [Abstract][Full Text] [Related]
11. Effects of morin on the pharmacokinetics of nicardipine after oral and intravenous administration of nicardipine in rats.
Piao YJ; Choi JS
J Pharm Pharmacol; 2008 May; 60(5):625-9. PubMed ID: 18416939
[TBL] [Abstract][Full Text] [Related]
12. Altered pharmacokinetics of paclitaxel by the concomitant use of morin in rats.
Choi BC; Choi JS; Han HK
Int J Pharm; 2006 Oct; 323(1-2):81-5. PubMed ID: 16806758
[TBL] [Abstract][Full Text] [Related]
13. Effects of morin on the pharmacokinetics of etoposide in rats.
Li X; Yun JK; Choi JS
Biopharm Drug Dispos; 2007 Apr; 28(3):151-6. PubMed ID: 17315145
[TBL] [Abstract][Full Text] [Related]
14. Effects of morin pretreatment on the pharmacokinetics of diltiazem and its major metabolite, desacetyldiltiazem in rats.
Choi HJ; Choi JS
Arch Pharm Res; 2005 Aug; 28(8):970-6. PubMed ID: 16178425
[TBL] [Abstract][Full Text] [Related]
15. Pre-clinical evidence of enhanced oral bioavailability of the P-glycoprotein substrate talinolol in combination with morin.
Pathak SM; Udupa N
Biopharm Drug Dispos; 2010 Mar; 31(2-3):202-14. PubMed ID: 20238375
[TBL] [Abstract][Full Text] [Related]
16. Effects of baicalein, an antioxidant, on the bioavailability of doxorubicin in rats: possible role of P-glycoprotein inhibition by baicalein.
Shin SC; Li C; Choi JS
Pharmazie; 2009 Sep; 64(9):579-83. PubMed ID: 19827298
[TBL] [Abstract][Full Text] [Related]
17. Enhanced bioavailability of etoposide after oral or intravenous administration of etoposide with kaempferol in rats.
Li C; Li X; Choi JS
Arch Pharm Res; 2009 Jan; 32(1):133-8. PubMed ID: 19183886
[TBL] [Abstract][Full Text] [Related]
18. Effects of morin on the pharmacokinetics of docetaxel in rats with 7,12-dimethylbenz[a]anthracene (DMBA)-induced mammary tumors.
Yang SH; Lee JH; Lee DY; Lee MG; Lyuk KC; Kim SH
Arch Pharm Res; 2011 Oct; 34(10):1729-34. PubMed ID: 22076773
[TBL] [Abstract][Full Text] [Related]
19. Liquid chromatography-mass spectrometry method for the quantification of tamoxifen and its metabolite 4-hydroxytamoxifen in rat plasma: application to interaction study with biochanin A (an isoflavone).
Singh SP; Wahajuddin ; Ali MM; Kohli K; Jain GK
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Oct; 879(27):2845-51. PubMed ID: 21890435
[TBL] [Abstract][Full Text] [Related]
20. Enhanced systemic availability of methotrexate in the presence of morin in rats.
Hong SS; Jin MJ; Han HK
Biopharm Drug Dispos; 2008 May; 29(4):189-93. PubMed ID: 18240155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
